What other stocks do shareholders of VBI Vaccines own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VBI Vaccines investors own include Teladoc Health (TDOC) , PhaseBio Pharmaceuticals (PHAS) , Amarin (AMRN) , Adverum Biotechnologies (ADVM) , Assertio (ASRT) , Activision Blizzard (ATVI) , Axsome Therapeutics (AXSM) , Boeing (BA) , Beyond Meat (BYND) and Cardlytics (CDLX) .

How do I buy shares of VBI Vaccines?

Shares of VBV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

TSE:VBV

VBI Vaccines (VBV) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free VBV Stock Alerts

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 1,300 shs
Average Volume: 3,637 shs
Market Capitalization: C$308.86 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get VBI Vaccines alerts:

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About VBI Vaccines Stock (TSE:VBV)

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. The company offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborns; and eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines that closely mimic the target virus. It is also developing congenital cytomegalovirus vaccine candidate for infectious disease; and therapeutic glioblastoma multiforme vaccine candidate for immuno-oncology. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. The company is headquartered in Cambridge, Massachusetts. VBI Vaccines Inc. is a subsidiary of FDS Pharma ASS.

Ad Crypto 101 Media

SHOCKING Crypto Leak…

Claim your free seat by clicking here now.

VBV Stock News Headlines

April 16, 2024 | msn.com

VBIV Stock Earnings: VBI Vaccines Beats EPS, Misses Revenue for Q4 2023

October 31, 2023 | morningstar.com

VBI Vaccines Inc VBIV

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

September 26, 2023 | usatoday.com

No, Pfizer COVID-19 vaccine doesn't cause 'VAIDS.' That's not a real condition | Fact check

September 23, 2023 | usatoday.com

Updated COVID-19 vaccine recommended for everyone; old, young, immunocompromised will benefit most

September 21, 2023 | nypost.com

The real data behind the new COVID vaccines the White House is pushing

September 15, 2023 | nypost.com

COVID vaccine pill that kills virus before it infects the body could be coming

August 30, 2023 | foxnews.com

Biden plans to ask Congress for funding to develop new COVID vaccine, may recommend shot for all

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

July 6, 2023 | msn.com

VBI Vaccines slides on discounted stock and warrants offering

July 5, 2023 | marketwatch.com

VBI Vaccines Shares Turn Lower, Erase After-Hours Gains

June 7, 2023 | msn.com

VBI Vaccines gains ahead of upcoming presentation on hep B shot

May 15, 2023 | msn.com

VBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Misses Revenue Estimates

April 14, 2023 | msn.com

Raymond James Maintains VBI Vaccines (VBIV) Outperform Recommendation

April 5, 2023 | marketwatch.com

VBI Vaccines to Cut Workforce by 30%-35%, Focus on Hepatitis B >VBIV

April 5, 2023 | marketwatch.com

VBI Vaccines Shares Plumb New Depths on Restructuring Plans >VBIV

April 4, 2023 | msn.com

VBI Vaccines to focus on hep B treatments, conduct 1-for-30 reverse stock split

March 30, 2023 | nypost.com

How mRNA vaccines could target everything from cancer to the plague

March 28, 2023 | nbcnews.com

Moderna CEO grilled over plan to raise Covid vaccine price at Senate hearing

March 15, 2023 | usatoday.com

People without insurance will still get free COVID vaccines once government's supply runs out

March 14, 2023 | theguardian.com

Florida surgeon general’s Covid vaccine claims harm public, health agencies say

March 13, 2023 | foxnews.com

LA County eases COVID vaccine, testing restrictions as emergency declarations end

February 24, 2023 | cnbc.com

Flu vaccine was 68% effective at preventing hospitalization in children but less protective for seniors this season

February 22, 2023 | reuters.com

Develop vaccines for all animal influenza strain, says incoming WHO chief scientist

February 22, 2023 | foxnews.com

Prior COVID infection provides just as much protection as vaccines, new study finds

February 20, 2023 | usnews.com

Two Vaccines May Soon Shield Seniors Against RSV

February 15, 2023 | marketwatch.com

The Rise of Virus-like Particles (VLPs) Vaccine Market Research 2023-2029: Opportunities and Challenges

See More Headlines

Receive VBV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: TSE
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: TSE:VBV
CUSIP: N/A
CIK: N/A
Web: www.vbivaccines.com
Phone: +1-617-8303031
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 14.29
Current Ratio: 2.64
Quick Ratio: 2.54

Sales & Book Value

Annual Sales: C$3.36 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: C$1.01 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 64,079,000
Free Float: N/A
Market Cap: C$308.86 million
Optionable: Not Optionable
Beta: N/A

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Mr. Jeff R. Baxter (Age 57)
CEO, Pres & Director
Dr. David Evander Anderson Ph.D. (Age 48)
Chief Scientific Officer
Ms. Athena Kartsaklis (Age 53)
Sr. VP of Fin., Principal Financial & Accounting Officer, Chief Compliance Officer
Ms. Nell Beattie (Age 30)
Chief Bus. Officer
Dr. Francisco Diaz-Mitoma M.D. (Age 63)
Ph.D., Chief Medical Officer

VBV Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of VBI Vaccines own?: Based on aggregate information from My MarketBeat watchlists, some companies that other VBI Vaccines investors own include Teladoc Health (TDOC), PhaseBio Pharmaceuticals (PHAS), Amarin (AMRN), Adverum Biotechnologies (ADVM), Assertio (ASRT), Activision Blizzard (ATVI), Axsome Therapeutics (AXSM), Boeing (BA), Beyond Meat (BYND) and Cardlytics (CDLX).
How do I buy shares of VBI Vaccines?: Shares of VBV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:VBV) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

VBI Vaccines (VBV) Stock Price, News & Analysis

About VBI Vaccines Stock (TSE:VBV)

VBV Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

VBV Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info